Skip to main content

Type 1 diabetes

Monoclonal antibody model

23-10-2023 | Type 1 diabetes | News

Teplizumab may PROTECT β-cell function in youth with newly diagnosed type 1 diabetes

Early treatment with the anti-CD3 monoclonal antibody teplizumab may help to preserve β-cell function in children and adolescents with newly diagnosed type 1 diabetes, results of the phase 3 PROTECT study show.

18-10-2023 | Type 1 diabetes | News

Automated insulin delivery benefits type 1 diabetes individuals at high hypoglycemia risk

Automated insulin delivery reduces hypoglycemia in people with type 1 diabetes at increased risk, improving their time spent in target glucose range.

Four out of ten

03-10-2023 | Type 1 diabetes | News

Four in 10 US adults with type 1 diabetes diagnosed after 30 years of age

Type 1 diabetes onset may be more common during adulthood than previously thought, which could increase the risk for it being misdiagnosed as type 2 diabetes.

12-09-2023 | Type 1 diabetes | News

Preservation of β-cell function with teplizumab in type 1 diabetes confirmed

Teplizumab consistently preserves the function of β-cells in people with type 1 diabetes as measured by higher C-peptide levels at 1 and 2 years post-treatment.

21-06-2023 | Cardiovascular disorders | News

Non-fasting remnant cholesterol shows mixed prognostic value for CVD by diabetes status

Real-world study data show that non-fasting remnant cholesterol levels are associated with a significantly increased risk for CVD in people without diabetes, with a similar, but nonsignificant, trend observed in those with diabetes.

02-06-2023 | Type 1 diabetes | News

Pregnancy-specific closed-loop system proves feasible for home use

Results of a pilot study show that a hybrid closed-loop insulin delivery system customized for pregnancy used by women with type 1 diabetes at home significantly improved their glucose outcomes.

19-05-2023 | Type 1 diabetes | News

Over 60s with type 1 diabetes show trust in Cambridge hybrid closed-loop system

The use of the Cambridge hybrid closed-loop insulin delivery system by older adults with type 1 diabetes mellitus is associated with “improved quality of life,” says an international team of researchers.

03-05-2023 | Islet transplantation | News

Early islet cell graft function predicts long-term outcomes

The function of an islet cell graft 28 days after the last infusion predicts 5-year outcomes, show data from the Collaborative Islet Transplant Registry.